From today’s Washington Post:
The D.C. Council voted 7 to 6 yesterday to give initial approval to legislation that would make the District the first jurisdiction in the country to license pharmaceutical sales representatives, a major blow to the prescription drug industry and one that could have national implications if states follow the District’s lead.
What else is pressing in D.C. these days?
Here is a statement from Ken Johnson, senior vice president of Pharmaceutical Research and Manufacturers of America, via a spokesman:
We regret that the council voted in favor of legislation that creates unnecessary financial burdens for the District of Columbia at a time when the money would be better spent addressing a wide array of health care challenges confronting the city including HIV/AIDS, diabetes and heart disease. .The bill passed by the council puts the city into a regulatory arena that has been effectively addressed by federal laws and federal government agencies for years.
City Councilman Marion Barry is right. (It happens now and then.) “Marion Barry (D-Ward 8) called the debate ‘misdirected energy.'”
Latest posts by NAM (see all)
- Manufacturers Win Several Website Design Awards - June 15, 2011
- China Makes Commitments on Trade, Intellectual Property - December 16, 2010
- ITC Details Widespread Theft of Intellectual Property in China - December 14, 2010